Definium Therapeutics (DFTX) Tax Rate (2021)
Definium Therapeutics (DFTX) reported Tax Rate of 4.35% for Q4 2021.
Definium Therapeutics (DFTX) has 1 years of Tax Rate data on file, last reported at 4.35% in Q4 2021.
- Quarterly Tax Rate changed N/A year-over-year to 4.35% in Q4 2021, while the trailing twelve-month figure through Sep 2022 was 4.56% (changed N/A YoY) and the FY2021 annual result came in at 2.33%, changed N/A from the prior year.
- Tax Rate held at 4.35% in Q4 2021 per DFTX's latest filing.
- Across five years, Tax Rate topped out at 4.35% in Q4 2021 and bottomed at 4.35% in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7.07 |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -4.35 |
| Dec 31, 2021 | -4.35 |